Participants 102 132 4
familial adenomatous polyposis
Participants 237 287 4
patients with familial adenomatous polyposis (FAP)
Participants 897 1022 3
M66I, P153L, E158K, V257M, E305X, E308G, and R492W-in 21 and 20 FAP patients, who received sulindac and placebo, respectively
Participants 1044 1055 6
41 patients
